Royal Bank of Canada’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-61
| Closed | -$1K | – | 7275 |
|
|
2024
Q1 | $1K | Buy |
+61
| New | +$1K | ﹤0.01% | 6478 |
|
|
2023
Q4 | – | Sell |
-1,209
| Closed | -$5K | – | 7265 |
|
|
2023
Q3 | $5K | Buy |
1,209
+597
| +98% | +$2.47K | ﹤0.01% | 6140 |
|
|
2023
Q2 | $3K | Buy |
612
+602
| +6,020% | +$2.95K | ﹤0.01% | 6363 |
|
|
2023
Q1 | $0 | Sell |
10
-28
| -74% | – | ﹤0.01% | 7137 |
|
|
2022
Q4 | $0 | Sell |
38
-31
| -45% | – | ﹤0.01% | 7440 |
|
|
2022
Q3 | $0 | Buy |
69
+35
| +103% | – | ﹤0.01% | 7526 |
|
|
2022
Q2 | $0 | Sell |
34
-15
| -31% | – | ﹤0.01% | 7400 |
|
|
2022
Q1 | $0 | Sell |
49
-766
| -94% | – | ﹤0.01% | 7530 |
|
|
2021
Q4 | $39K | Buy |
815
+753
| +1,215% | +$36K | ﹤0.01% | 5985 |
|
|
2021
Q3 | $9K | Buy |
62
+18
| +41% | +$2.61K | ﹤0.01% | 6492 |
|
|
2021
Q2 | $5K | Sell |
44
-17
| -28% | -$1.93K | ﹤0.01% | 6582 |
|
|
2021
Q1 | $6K | Buy |
+61
| New | +$6K | ﹤0.01% | 6508 |
|